DUBLIN, /PRNewswire/ — The “Life Science Analytics Global Market Report 2022” report has been added to ResearchAndMarkets.com’s offering. The global life science analytics market is expected to grow from $21.16 billion in 2021 to $24.09 billion in 2022… Read More
VANCOUVER, BC — InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the research, development and manufacturing of rare cannabinoids and cannabinoid analogs, today announces an update on… Read More
VANCOUVER, BC & HOUSTON, TX — Virogin Biotech, a clinical-stage biotech company, and The University of Texas MD Anderson Cancer Center today announced a strategic collaboration to accelerate the development of investigational… Read More
VANCOUVER, BC – NervGen Pharma Corp. (TSX-V: NGEN) (OTCQX: NGENF)(“NervGen” or the “Company”), a clinical stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage, will present… Read More
NEW YORK — Pfizer Inc. (NYSE:PFE) today announced that its investigational Group B Streptococcus (GBS) vaccine candidate, GBS6 or PF-06760805, received Breakthrough Therapy Designation from the U.S. Food and Drug Administration… Read More
